Novel mutations in CRB1 and ABCA4 genes cause Leber congenital amaurosis and Stargardt disease in a Swedish family
- PMID: 23443024
- PMCID: PMC3798833
- DOI: 10.1038/ejhg.2013.23
Novel mutations in CRB1 and ABCA4 genes cause Leber congenital amaurosis and Stargardt disease in a Swedish family
Abstract
This study aimed to identify genetic mechanisms underlying severe retinal degeneration in one large family from northern Sweden, members of which presented with early-onset autosomal recessive retinitis pigmentosa and juvenile macular dystrophy. The clinical records of affected family members were analysed retrospectively and ophthalmological and electrophysiological examinations were performed in selected cases. Mutation screening was initially performed with microarrays, interrogating known mutations in the genes associated with recessive retinitis pigmentosa, Leber congenital amaurosis and Stargardt disease. Searching for homozygous regions with putative causative disease genes was done by high-density SNP-array genotyping, followed by segregation analysis of the family members. Two distinct phenotypes of retinal dystrophy, Leber congenital amaurosis and Stargardt disease were present in the family. In the family, four patients with Leber congenital amaurosis were homozygous for a novel c.2557C>T (p.Q853X) mutation in the CRB1 gene, while of two cases with Stargardt disease, one was homozygous for c.5461-10T>C in the ABCA4 gene and another was carrier of the same mutation and a novel ABCA4 mutation c.4773+3A>G. Sequence analysis of the entire ABCA4 gene in patients with Stargardt disease revealed complex alleles with additional sequence variants, which were evaluated by bioinformatics tools. In conclusion, presence of different genetic mechanisms resulting in variable phenotype within the family is not rare and can challenge molecular geneticists, ophthalmologists and genetic counsellors.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3798833/bin/ejhg201323f1.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3798833/bin/ejhg201323f2.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3798833/bin/ejhg201323f3.gif)
Similar articles
-
Genetic heterogeneity and clinical outcome in a Swedish family with retinal degeneration caused by mutations in CRB1 and ABCA4 genes.Adv Exp Med Biol. 2014;801:177-83. doi: 10.1007/978-1-4614-3209-8_23. Adv Exp Med Biol. 2014. PMID: 24664696
-
Molecular analysis of ABCA4 and CRB1 genes in a Spanish family segregating both Stargardt disease and autosomal recessive retinitis pigmentosa.Mol Vis. 2008 Feb 4;14:262-7. Mol Vis. 2008. PMID: 18334942 Free PMC article.
-
Coat's like vasculopathy in leber congenital amaurosis secondary to homozygous mutations in CRB1: a case report and discussion of the management options.BMC Res Notes. 2016 Feb 13;9:91. doi: 10.1186/s13104-016-1917-6. BMC Res Notes. 2016. PMID: 26872607 Free PMC article.
-
CRB1-Related Leber Congenital Amaurosis: Reporting Novel Pathogenic Variants and a Brief Review on Mutations Spectrum.Iran Biomed J. 2019 Sep;23(5):362-8. doi: 10.29252/.23.5.362. Epub 2019 May 19. Iran Biomed J. 2019. PMID: 31103025 Free PMC article. Review.
-
[From gene to disease: from the ABCA4 gene to Stargardt disease, cone-rod dystrophy and retinitis pigmentosa].Ned Tijdschr Geneeskd. 2002 Aug 24;146(34):1581-4. Ned Tijdschr Geneeskd. 2002. PMID: 12224481 Review. Dutch.
Cited by
-
Genotype-Phenotype of CRB1-Associated Early-Onset Retinal Dystrophy: Novel Insights on Retinal Architecture and Therapeutic Window for Clinical Trials.Invest Ophthalmol Vis Sci. 2024 Mar 5;65(3):11. doi: 10.1167/iovs.65.3.11. Invest Ophthalmol Vis Sci. 2024. PMID: 38466290 Free PMC article.
-
Antisense oligonucleotide therapy corrects splicing in the common Stargardt disease type 1-causing variant ABCA4 c.5461-10T>C.Mol Ther Nucleic Acids. 2023 Feb 18;31:674-688. doi: 10.1016/j.omtn.2023.02.020. eCollection 2023 Mar 14. Mol Ther Nucleic Acids. 2023. PMID: 36910710 Free PMC article.
-
Genetic Diagnosis for 64 Patients with Inherited Retinal Disease.Genes (Basel). 2022 Dec 26;14(1):74. doi: 10.3390/genes14010074. Genes (Basel). 2022. PMID: 36672815 Free PMC article.
-
CRISPR/Cas9-A Promising Therapeutic Tool to Cure Blindness: Current Scenario and Future Prospects.Int J Mol Sci. 2022 Sep 29;23(19):11482. doi: 10.3390/ijms231911482. Int J Mol Sci. 2022. PMID: 36232782 Free PMC article. Review.
-
An Overview of the Genetics of ABCA4 Retinopathies, an Evolving Story.Genes (Basel). 2021 Aug 13;12(8):1241. doi: 10.3390/genes12081241. Genes (Basel). 2021. PMID: 34440414 Free PMC article. Review.
References
-
- Chung DC, Traboulsi EI. Leber congenital amaurosis: clinical correlations with genotypes, gene therapy trials update, and future directions. J AAPOS. 2009;13:587–592. - PubMed
-
- Hanein S, Perrault I, Gerber S, et al. Leber congenital amaurosis: comprehensive survey of the genetic heterogeneity, refinement of the clinical definition, and genotype-phenotype correlations as a strategy for molecular diagnosis. Hum Mutat. 2004;23:306–317. - PubMed
-
- Senechal A, Humbert G, Surget MO, et al. Screening genes of the retinoid metabolism: novel LRAT mutation in leber congenital amaurosis. Am J Ophthalmol. 2006;142:702–704. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical